Wendy F Dicicco Akari Therapeutics PLC (AKTX) insider trading activity

AKTX Quotes by TradingView

Wendy F Dicicco is Interim CFO of Akari Therapeutics Plc. Currently has a direct ownership of 158 Million shares of AKTX, which is worth approximately $439 Million. The most recent transaction as insider was on May 01, 2024, when has been sold 158,473,915 shares (Ordinary shares, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 158M
0% 3M change
n/a 12M change
Total Value Held $439 Million

WENDY F DICICCO Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 01 2024
BUY
Grant, award, or other acquisition
-
158,473,915 Added 50.0%
158,473,915 Ordinary shares, par v...

Also insider at

EYPT
EyePoint Pharmaceuticals, Inc. Healthcare
RCOR
Renovacor, Inc. Healthcare
Chief Financial Officer
SWKH
SWK Holdings Corp Financial Services
Director
WFD

Wendy F Dicicco

Interim CFO
Dallas, TX

Track Institutional and Insider Activities on AKTX

Follow Akari Therapeutics Plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKTX shares.

Notify only if

Insider Trading

Get notified when an Akari Therapeutics PLC insider buys or sells AKTX shares.

Notify only if

News

Receive news related to Akari Therapeutics Plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AKTX